Diamond‐Lipid Hybrids Enhance Chemotherapeutic Tolerance and Mediate Tumor Regression
暂无分享,去创建一个
Dean Ho | Edward Kai-Hua Chow | Eiji Osawa | J. Bishop | D. Ho | E. Ōsawa | E. Chow | Laura Moore | J. Michael Bishop | L. Moore
[1] Mark B. Carter,et al. The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers , 2011, Nature materials.
[2] Y. Gogotsi,et al. Wet chemistry route to hydrophobic blue fluorescent nanodiamond. , 2009, Journal of the American Chemical Society.
[3] Kazuhiro Ikeda,et al. Real-time background-free selective imaging of fluorescent nanodiamonds in vivo. , 2012, Nano letters.
[4] Erik Pierstorff,et al. Active nanodiamond hydrogels for chemotherapeutic delivery. , 2007, Nano letters.
[5] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[6] A. Gabizon,et al. Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin , 2012, Drugs.
[7] Dean Ho,et al. Nanodiamond Vectors Functionalized with Polyethylenimine for siRNA Delivery , 2010 .
[8] Milos Nesladek,et al. Luminescence of Nanodiamond Driven by Atomic Functionalization: Towards Novel Detection Principles , 2012 .
[9] F. Szoka,et al. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. , 2009, Accounts of chemical research.
[10] Lei Tao,et al. A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond , 2012 .
[11] Wei Zhao,et al. Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes , 2011, International journal of nanomedicine.
[12] U. Nielsen,et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.
[13] G Blume,et al. Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.
[14] Xue-Qing Zhang,et al. Triggered release of therapeutic antibodies from nanodiamond complexes. , 2011, Nanoscale.
[15] Jui‐I Chao,et al. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy , 2010, Nanotechnology.
[16] C. Papadimitriou,et al. EGFR expression and activation are common in HER2 positive and triple-negative breast tumours. , 2010, Histology and histopathology.
[17] E. Zubarev,et al. Paclitaxel-functionalized gold nanoparticles. , 2007, Journal of the American Chemical Society.
[18] Yury Gogotsi,et al. Fluorescent PLLA-nanodiamond composites for bone tissue engineering. , 2011, Biomaterials.
[19] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[20] Tiancheng Wang,et al. Pulmonary toxicity and translocation of nanodiamonds in mice , 2010 .
[21] Anke Krüger,et al. Surface functionalisation of detonation diamond suitable for biological applications , 2006 .
[22] D. Cunningham,et al. Targeting the human EGFR family in esophagogastric cancer , 2011, Nature Reviews Clinical Oncology.
[23] Rakesh K. Jain,et al. Transport of molecules across tumor vasculature , 2004, Cancer and Metastasis Reviews.
[24] G. Gregoriadis,et al. Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. , 1985, Biochimica et biophysica acta.
[25] T. Jovin,et al. Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes. , 2010, Bioconjugate chemistry.
[26] D. Papahadjopoulos,et al. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.
[27] Dean Ho,et al. Multimodal Nanodiamond Drug Delivery Carriers for Selective Targeting, Imaging, and Enhanced Chemotherapeutic Efficacy , 2011, Advanced materials.
[28] C. Mamot,et al. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. , 2005, Cancer research.
[29] Dean Ho,et al. Gd(III)-nanodiamond conjugates for MRI contrast enhancement. , 2010, Nano letters.
[30] M. Saif,et al. Biology of Colorectal Cancer , 2010, Cancer journal.
[31] A. Goga,et al. Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment , 2011, Science Translational Medicine.
[32] Tadashi Kobayashi,et al. EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer. , 2009, Oncology reports.
[33] Yury Gogotsi,et al. The properties and applications of nanodiamonds. , 2011, Nature nanotechnology.
[34] Dean Ho,et al. Nanodiamond-mediated delivery of water-insoluble therapeutics. , 2009, ACS nano.
[35] Yuanwei Chen,et al. Biodistribution and fate of nanodiamonds in vivo , 2009 .
[36] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[37] Dean Ho,et al. Polymer-functionalized Nanodiamond Platforms as Vehicles for Gene Delivery Keywords: Nanodiamonds · Gene Delivery · Nanocarrier · Transfection · Low Molecular Weight Polyethyleneimine (lmw Pei) , 2022 .
[38] J. Gariépy,et al. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] George C Schatz,et al. Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier. , 2011, Molecular pharmaceutics.
[40] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[41] K. Matthay,et al. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.
[42] M. Yen,et al. Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up. , 2006, Gynecologic oncology.
[43] I. Ellis,et al. An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens , 2006, Journal of Clinical Pathology.
[44] Ian O Ellis,et al. Prognostic markers in triple‐negative breast cancer , 2007, Cancer.
[45] Haojie Lu,et al. Immobilization of enzyme on detonation nanodiamond for highly efficient proteolysis. , 2010, Talanta.
[46] Wei Zhang,et al. Genetic and epigenetic changes in lung carcinoma and their clinical implications , 2011, Modern Pathology.
[47] K. Kono,et al. Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells. , 2002, International journal of pharmaceutics.
[48] Huan-Cheng Chang,et al. In vivo imaging and toxicity assessments of fluorescent nanodiamonds in Caenorhabditis elegans. , 2010, Nano letters.
[49] Michael Sternberg,et al. Crystallinity and surface electrostatics of diamond nanocrystals , 2007 .